A Phase 1 Study of PRT3789 in Participants with Advanced or Metastatic Solid Tumors with a SMARCA4 Mutation

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-502850-14-00

Acronym

PRT3789-01

Enrollment

Registered

2023-08-21

Start date

2023-09-25

Completion date

2025-10-01

Last updated

2025-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder cancer, Breast Cancer, Colon adenocarcinoma, Esophageal/gastric cancer, gastroesophageal junction, gastrointestinal cancer, Head and Neck Squamous cell Carcinoma, Lung Adenocarcinoma, Lung Squamous cell carcinoma, non-small cell lung cancer (NSCLC), Ovarian Cancer, Pancreatic Cancer, Skin Cancer/Melanoma, Uterine/Endometrioid Adenocarcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Countries

France, Germany, Netherlands, Spain

Outcome results